- World Pharma News Home » Financial » Novartis completes acquisition of 25% stake in Alcon from Nestlé
(a free service delivered by FeedBurner)
Novartis has acquired a 25% stake in Alcon Inc. (NYSE: ACL) as part of a definitive agreement with Nestlé S.A. reached in April 2008 that provides the right to acquire majority ownership of the world leader in eye care in two steps.
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Comments